Sign up to save your podcasts
Or
Share 258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.
View all episodes
By STAT
4.5
320320 ratings
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.
More shows like The Readout Loud
View all
Odd Lots
1,976 Listeners
Nature Podcast
755 Listeners
The a16z Show
1,096 Listeners
Science Magazine Podcast
816 Listeners
What the Health? From KFF Health News
498 Listeners
The Long Run with Luke Timmerman
127 Listeners
The Journal.
6,118 Listeners
Biotech 2050 Podcast
62 Listeners
Business Of Biotech
87 Listeners
BioCentury This Week
35 Listeners
Hard Fork
5,594 Listeners
First Opinion Podcast
55 Listeners
Biotech Hangout
21 Listeners
Money Stuff: The Podcast
397 Listeners
The Top Line
15 Listeners
The BioCentury Show
12 Listeners